In vivo evaluation of retinal ganglion cells degeneration in eyes with branch retinal vein occlusion

Purpose To analyse the topographic changes in retinal ganglion cells (RGCs) in eyes with unilateral naive branch retinal vein occlusion (BRVO) in comparison to normal fellow eyes and to healthy control eyes. Methods We performed a retrospective analysis of 66 eyes (33 subjects) with naive unilateral BRVO who underwent spectral-domain optical coherence tomography using Cirrus HD-OCT. We also included 67 eyes of 48 age-matched healthy volunteers as control group. Average, minimum and sectoral macular ganglion cell-inner plexiform layer (GCIPL) thickness, macular retinal nerve fibre layer (RNFL) thickness and outer retinal thickness were collected. Comparison of the GCIPL, RNFL and outer retinal thicknesses among study eyes, normal fellow eyes and control groups was performed. Results The average and minimum macular GCIPL thicknesses were constantly and diffusely reduced in BRVO compared with normal fellow eyes and healthy controls (p<0.001 for each GCIPL sector). The average macular RNFL thickness was reduced in BRVO eyes compared with normal fellow eyes (p=0.01) and tended to be lower than controls (p=0.07). The minimum RNFL thickness in eyes with BRVO was significantly reduced when compared with fellow eyes (p<0.001) and control eyes (p<0.001). The average outer retina thickness was thicker in BRVO eyes compared with both fellow eyes (p<0.001) and controls (p<0.001). Conclusions A significant reduction of the macular GCIPL and RNFL thicknesses was observed in eyes with BRVO. This finding is suggestive of RGCs degeneration; the neuroprotective effect of current therapeutic options might be an important consideration when evaluating treatment strategies and prognosticating visual outcome in BRVO eyes.

[1]  J. Chhablani,et al.  Retinal ganglion cells thinning in eyes with nonproliferative idiopathic macular telangiectasia type 2A. , 2015, Investigative ophthalmology & visual science.

[2]  Dong Myung Kim,et al.  Macular ganglion cell imaging study: interocular symmetry of ganglion cell-inner plexiform layer thickness in normal healthy eyes. , 2015, American journal of ophthalmology.

[3]  M. Shimura,et al.  Photopic negative response in branch retinal vein occlusion with macular edema , 2015, International Ophthalmology.

[4]  A. Rao,et al.  Macular ganglion cell/inner plexiform layer measurements by spectral domain optical coherence tomography for detection of early glaucoma and comparison to retinal nerve fiber layer measurements. , 2014, American journal of ophthalmology.

[5]  Michel Paques,et al.  Spectral-Domain Optical Coherence Tomography of the Rodent Eye: Highlighting Layers of the Outer Retina Using Signal Averaging and Comparison with Histology , 2014, PloS one.

[6]  Jung-Yeul Kim,et al.  SECTORAL RETINAL NERVE FIBER LAYER THINNING IN BRANCH RETINAL VEIN OCCLUSION , 2014, Retina.

[7]  Joon-Won Kang,et al.  Correlation between optical coherence tomographic hyperreflective foci and visual outcomes after intravitreal bevacizumab for macular edema in branch retinal vein occlusion , 2014, Graefe's Archive for Clinical and Experimental Ophthalmology.

[8]  Xiao-Xin Li,et al.  Neuroprotective effect of minocycline in a rat model of branch retinal vein occlusion. , 2013, Experimental eye research.

[9]  Ki Ho Park,et al.  Macular ganglion cell imaging study: glaucoma diagnostic accuracy of spectral-domain optical coherence tomography. , 2013, Investigative ophthalmology & visual science.

[10]  Sven Schippling,et al.  Retinal ganglion cell and inner plexiform layer thinning in clinically isolated syndrome , 2013, Multiple sclerosis.

[11]  H. Koh,et al.  Spectral-domain optical coherence tomography (SD-OCT) patterns and response to intravitreal bevacizumab therapy in macular edema associated with branch retinal vein occlusion , 2013, Graefe's Archive for Clinical and Experimental Ophthalmology.

[12]  P. Campochiaro,et al.  Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study. , 2011, Ophthalmology.

[13]  Allen C Ho,et al.  Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study. , 2011, Ophthalmology.

[14]  P. Mitchell,et al.  Natural history of branch retinal vein occlusion: an evidence-based systematic review. , 2010, Ophthalmology.

[15]  M. Blumenkranz,et al.  Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. , 2010, Ophthalmology.

[16]  Ingrid U Scott,et al.  A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5. , 2009, Archives of ophthalmology.

[17]  E. Ling,et al.  Hypoxia-ischemia and retinal ganglion cell damage , 2008, Clinical ophthalmology.

[18]  E. Ling,et al.  Blood–retinal barrier disruption and ultrastructural changes in the hypoxic retina in adult rats: the beneficial effect of melatonin administration , 2007, The Journal of pathology.

[19]  G. Leoncini,et al.  Platelet activation by collagen is increased in retinal vein occlusion , 2007, Thrombosis and Haemostasis.

[20]  F. Medeiros,et al.  Progressive Localized Retinal Nerve Fiber Layer Loss Following a Retinal Cotton Wool Spot , 2007, Seminars in ophthalmology.

[21]  G. Benedek,et al.  Hypobaric hypoxia reduces the amplitude of oscillatory potentials in the human ERG , 2007, Documenta Ophthalmologica.

[22]  N. Osborne,et al.  Retinal ischemia: mechanisms of damage and potential therapeutic strategies , 2004, Progress in Retinal and Eye Research.

[23]  E. Chihara,et al.  Topographic changes in the optic disc in eyes with cotton-wool spots and primary open-angle glaucoma , 2004, Graefe's Archive for Clinical and Experimental Ophthalmology.

[24]  T. Kuroiwa,et al.  The biphasic opening of the blood-brain barrier to proteins following temporary middle cerebral artery occlusion , 2004, Acta Neuropathologica.

[25]  J. Lovasik,et al.  Neuroretinal function during mild systemic hypoxia. , 2002, Aviation, space, and environmental medicine.

[26]  F. Block,et al.  Effects of antioxidants on ischemic retinal dysfunction. , 1997, Experimental eye research.

[27]  S. Pietri,et al.  Free radicals in rabbit retina under ocular hyperpressure and functional consequences. , 1997, Experimental eye research.

[28]  M. Droy-lefaix,et al.  Direct measurement of free radicals in ischemic/reperfused diabetic rat retina. , 1997, Clinical neuroscience.

[29]  A. Hayashi,et al.  Increase of protein tyrosine phosphorylation in rat retina after ischemia-reperfusion injury. , 1996, Investigative ophthalmology & visual science.

[30]  H. Bradford,et al.  Glutamate Release in Experimental Ischaemia of the Retina: An Approach Using Microdialysis , 1992, Journal of neurochemistry.

[31]  Argon laser photocoagulation for macular edema in branch vein occlusion. The Branch Vein Occlusion Study Group. , 1984, American journal of ophthalmology.

[32]  W R Green,et al.  Histopathologic study of nine branch retinal vein occlusions. , 1982, Archives of ophthalmology.

[33]  N. Ashton,et al.  Experimental retinal branch vein occlusion in rhesus monkeys. III. Histopathological and electron microscopical studies. , 1979, The British journal of ophthalmology.

[34]  C. Dollery,et al.  Experimental retinal branch vein occlusion in rhesus monkeys. I. Clinical appearances. , 1979, The British journal of ophthalmology.